AMED:XETRA:XETRA-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 322.5

Change

+4.65 (+1.46)%

Market Cap

USD 1.22B

Volume

166.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.91 (-1.97%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.61 (+0.61%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.51 (-2.11%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.12 (-0.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.16%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.20 (-0.85%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.11 (-0.19%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.12 (+1.20%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.07 (+0.06%)

USD 12.26B

ETFs Containing AMED:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.16% 88% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.16% 89% A- 83% B
Trailing 12 Months  
Capital Gain 5.53% 56% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.53% 57% F 57% F
Trailing 5 Years  
Capital Gain 86.33% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.33% 74% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.94% 66% D+ 66% D+
Dividend Return 9.94% 65% D 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.18% 44% F 55% F
Risk Adjusted Return 75.39% 66% D+ 71% C-
Market Capitalization 1.22B 85% B 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.